HOME >> MEDICINE >> NEWS
Crohn's & Colitis Foundation of America selects Wiley to publish Inflammatory Bowel Diseases

Global publisher John Wiley & Sons, Inc., announced today that it has been selected by the Crohn's & Colitis Foundation of America (CCFA) as the new publisher of the Foundation's official journal, Inflammatory Bowel Diseases, effective January 2007.

Inflammatory Bowel Diseases is the first and only peer-reviewed journal dedicated exclusively to inflammatory bowel diseases. Now in its tenth year, the journal provides articles of interest to professionals treating patients and conducting research in this expanding field. Each issue contains articles on clinical and basic science, as well as reviews of treatments and ground-breaking research.

"This is a wonderful partnership opportunity for Wiley," said Shawn Morton, Wiley Vice President and Publishing Director, Medicine. "We look forward to facilitating communication about the mechanisms and treatment of Crohn's disease and ulcerative colitis through this premier publication in collaboration with CCFA."

Wiley will begin publishing the journal in 2007 and will continue to make it available in print and online as a benefit of CCFA Professional Membership, and through subscription to other individual and institutional customers. Inflammatory Bowel Diseases will be available online via Wiley InterScience (www.interscience.wiley.com), the company's online publishing platform.

"CCFA is extremely proud of this journal, which provides an important forum for the best and the brightest scientists and clinicians in our field to report on the advances that are being made," said Jonathan Braun, M.D., Ph.D., Professor, David Geffen School of Medicine, UCLA Medical Center, and Chair of CCFA's National Scientific Advisory Committee. "We're confident that our partnership with Wiley will allow us to build on the journal's success, and expand our outreach to the medical community."


'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
20-Mar-2006


Page: 1

Related medicine news :

1. ECP may be effective in treating Crohns disease
2. Smoking influences Crohns disease
3. Researchers identify new therapy for patients with Crohns disease
4. Canada high in ulcerative colitis and Crohns cases: Is Canada too clean?
5. Penn State research shows withdrawal drug offers relief for Crohns sufferers
6. Immune signals of variations of a single gene linked to more severe Crohns disease
7. Biologic therapies lead evolution of Crohns treatments
8. FDA grants priority review of Remicade® for children with Crohns disease
9. New insight into cause of Crohns disease
10. Improved diagnostic technology for Crohns disease
11. UVa Health System wins renewal of $6.2 million grant for Crohns disease research

Post Your Comments:
(Date:6/18/2013)... Seven-year-old Riley Salz of Encino, California, is ... 40 hours a week of applied behavior analysis (ABA) ... for Autism and Related Disorders (CARD). Riley has been ... experienced remarkable progress, including learning to speak, starting conversations, ... journey through autism is now featured in CARD’s “Mission ...
(Date:6/18/2013)... Medical Center clinical researchers have launched an innovative ... evaluate the ability of a patient,s own stem ... peripheral arterial disease (PAD). , Led by ... University Hospitals Case Medical Center,s Harrington Heart & ... Western Reserve University School of Medicine, the clinical ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 More than 1.1 ... living with HIV/AIDS, according to the Centers for Disease Control ... they are infected. In support of National HIV Testing Day ... Security Disability Insurance (SSDI) representation, the CDC and other ... , The CDC reports about 50,000 new HIV infections ...
(Date:6/18/2013)... 18, 2013 myCNAjobs announces the addition ... downloads, articles, and tips to the Caregiver Resources Center. ... for the 10,000+ retiring baby boomers each day, the ... caregiver job resources has never been greater. ... community, recently launched the first-ever free resource center ...
(Date:6/18/2013)... A new $119 million industry is taking the ... redefining the way consumers get their seafood. , ... chefs on the Emerald Coast panhandle of Northwest Florida ... the promising industry of aquaculture. , The word “sustainable” ... to fully partake in the effort, especially when it ...
Breaking Medicine News(10 mins):Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:New $119 Million Industry Swimming Up the East Coast 2
(Date:6/18/2013)... FRANKLIN LAKES, N.J. and NEW YORK ... (Becton, Dickinson and Company) (NYSE: BDX ) are ... insulin infusion and glucose sensing technologies through a new collaboration ... existing JDRF-BD collaborations focused on type 1 diabetes (T1D). ... via an insulin pump – requiring a catheter to be ...
(Date:6/18/2013)... EMERYVILLE, Calif. , June 18, 2013 /PRNewswire/ ... from a Phase 2/3 clinical trial of ADS-5102 ... significant improvement in levodopa-induced dyskinesia (LID) as measured ... placebo in the Unified Dyskinesia Rating Scale (UDysRS). ... intended for once-nightly administration that is being studied ...
(Date:6/17/2013)... , June 17, 2013 Velplex, LLC ... , a technology platform that connects buyers and sellers ... being an industry leader. Why? It,s ... TopProdeals™ are intimately familiar with the dental industry. They ... community and have diligently worked to negotiate some of ...
Breaking Medicine Technology:JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
Cached News: